Washington Trust CO Corbus Pharmaceuticals Holdings, Inc. Transaction History

Washington Trust CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$0.6 - $1.11 $1,500 - $2,775	-2,500 Closed	0 $0
Q2 2020 Aug 04, 2020	SELL	$4.79 - $8.39 $9,580 - $16,780	-2,000 Reduced 44.44%	2,500 $20,000
Q1 2020 May 07, 2020	BUY	$3.44 - $7.21 $15,480 - $32,445	4,500 New	4,500 $24,000
Q3 2018 Nov 13, 2018	SELL	$4.65 - $7.95 $20,925 - $35,775	-4,500 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$5.05 - $6.8 $22,725 - $30,600	4,500 New	4,500 $23,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $1.63B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Washington Trust CO, based on Form 13F filings with the SEC.

Stay updated on Washington Trust CO with notifications on news.